论文部分内容阅读
目的:探讨缩宫素单用及联合卡孕栓的临床效果比较。方法:选取我院2013年1月份以后52例剖宫产分娩产妇进行研究,以随机为基本原则将其分为观察组27例、对照组25例。对照组单用缩宫素治疗,在此基础上,观察组予以卡孕栓进行联合治疗。观察两组不良事件情况及剖宫产术中、产后二十四小时出血情况。结果:观察组不良事件发生概率数据为11.11%,低于对照组(16.00%),但相比较而言差异性不显著,P>0.05;观察组与对照组剖宫产术中出血量对比差异不明显,P>0.05;产后二十四小时出血情况方面,观察组数据为(378.34±22.79)ml,明显低于对照组,P<0.05。结论:缩宫素与卡孕栓联合应用于剖宫产分娩中,相比单用缩宫素而言效果更佳,能够更好的控制出血情况,有效预防产后出血,且不良事件发生风险较低,安全性高。
Objective: To compare the clinical effects of oxytocin alone and combined with card. Methods: 52 cases of cesarean delivery in our hospital after January 2013 were selected and randomly divided into observation group (27 cases) and control group (25 cases). The control group was treated with oxytocin alone. On the basis of this, the observation group was treated with carboplatin for combination therapy. Adverse events were observed in two groups and cesarean section, postpartum hemorrhage twenty-four hours. Results: The incidence of adverse events in the observation group was 11.11%, which was lower than that in the control group (16.00%), but the difference was insignificant compared with the control group (P> 0.05). The difference of bleeding volume between the observation group and the control group in cesarean section Obviously, P> 0.05; In the 24 hours postpartum hemorrhage, the observation group data (378.34 ± 22.79) ml, significantly lower than the control group, P <0.05. Conclusions: The combination of oxytocin and carbamazepine in cesarean delivery is better than that of oxytocin alone, which can better control the bleeding, prevent postpartum hemorrhage, and have a higher risk of adverse events Low, safe.